Finance

Lists
000153:SHE
Anhui Fengyuan Pharmaceutical Co., Ltd.
CN¥6.11
+0.49%
(+0.030) 1D
Sep 30, 3:04:12 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000153...
Open
CN¥6.10
High
CN¥6.17
Low
CN¥6.08
Mkt. cap
2.84B
Avg. vol.
20.69M
Volume
7.46M
Dividend
1.64%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 18, 2026
P/E ratio
30.07
52-wk high
CN¥7.35
52-wk low
CN¥4.95
EPS
CN¥0.20
Shares outstanding
464.69M
No. of employees
4K
Open
CN¥6.10
High
CN¥6.17
Low
CN¥6.08
Mkt. cap
2.84B
Avg. vol.
20.69M
Volume
7.46M
Dividend
1.64%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 18, 2026
P/E ratio
30.07
52-wk high
CN¥7.35
52-wk low
CN¥4.95
EPS
CN¥0.20
Shares outstanding
464.69M
No. of employees
4K
News stories
From web sources and news partners
About Anhui Fengyuan Pharmaceutical Co., Ltd.
CEO-
Employees4.28K
FoundedAug 30, 1997
Headquarters-
SectorPharmaceutical industry
Websitebbcayy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.10B
733.07M
835.92M
835.44M
Cost of goods sold
948.42M
580.93M
644.51M
665.86M
Cost of revenue
948.42M
580.93M
644.51M
665.86M
Research and development expenses
12.18M
4.77M
6.42M
14.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
109.42M
108.52M
129.73M
123.17M
Operating expense
132.21M
124.19M
140.58M
150.29M
Total operating expenses
1.08B
705.12M
785.09M
816.15M
Operating income
17.37M
27.95M
50.84M
19.29M
Other non operating income
103.61K
-3.08M
-376.70K
-230.38K
EBT including unusual items
25.52M
11.23M
44.44M
30.26M
EBT excluding unusual items
16.56M
16.34M
45.18M
22.87M
Income tax expense
2.30M
14.64M
8.00M
-3.58M
Effective tax rate
9.03%
130.37%
18.01%
-11.84%
Other operating expenses
8.52M
421.98K
1.82M
12.40M
Net income
24.01M
-868.40K
37.01M
34.28M
Net profit margin
2.19%
-0.12%
4.43%
4.10%
Earnings per share
-
-
-
-
Interest and investment income
9.22M
365.49K
2.01M
11.70M
Interest expense
-9.85M
-9.19M
-7.29M
-7.83M
Net interest expenses
-635.10K
-8.83M
-5.28M
3.86M
Depreciation and amortization charges
-
-
-
-
EBITDA
42.47M
58.19M
81.08M
48.96M
Gain or loss from assets sale
-
326.42K
-
808.00
AI content may include mistakes. Learn more
Google apps